Home›Stock Screener›Procter & Gamble Health›Financial Statements

Procter & Gamble Health Complete Financial Statements

11 Years of Data
2026 - 2015

In FY2025, Procter & Gamble Health (PGHL) reported revenue ₹945 Cr, net profit ₹234 Cr and EPS ₹141.00, with a net profit margin of 24.8% and ROE of 44.6%. Full financial statements from FY2015 to FY2026 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore Procter & Gamble Health intrinsic price to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 24.76% 2025 data
EBITDA Margin 34.81% 2025 data
Operating Margin 34.00% 2025 data
Return on Assets 27.82% 2025 data
Return on Equity 44.57% 2025 data

Balance Sheet Ratios

Current Ratio 8.97 2025 data
Equity Ratio 62.43% 2025 data
Asset Turnover 1.12 2025 data

PGHL Revenue, Net Profit & EBITDA — Year-on-Year Growth

PGHL YoY (March 2024 vs March 2025) — revenue -19.0%, net profit +16.4%, EBITDA +2.2%, expenses -27.1%. For live price, earnings ratios and company overview, see PGHL stock price BSE.

Revenue Growth
-19.0%
Year-over-Year
Net Profit Growth
+16.4%
Year-over-Year
EBITDA Growth
+2.2%
Year-over-Year
Expense Growth
-27.1%
Year-over-Year
Assets Growth
+5.9%
Year-over-Year
Equity Growth
-2.2%
Year-over-Year
Operating Cash Flow Growth
-25.9%
Year-over-Year
Investing Cash Flow Growth
+242.9%
Year-over-Year
Financing Cash Flow Growth
+43.8%
Year-over-Year

PGHL Income Statement — Revenue, EBITDA & Net Profit

Procter & Gamble Health revenue ₹945 Cr, EBITDA ₹329 Cr, net profit ₹234 Cr, EPS ₹141.00 (2025) — net profit margin 24.8%. Review Procter & Gamble Health P/E valuation to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2018 March 2017 March 2016 March 2015
Revenue 945 1,167 1,248 1,128 1,027 1,425 873 722 1,017 963
Expenses 616 845 905 847 763 1,041 701 621 877 856
EBITDA 329 322 343 281 264 384 173 101 140 107
Operating Profit Margin % 34.00% 27.00% 26.00% 24.00% 24.00% 23.00% 17.00% 11.00% 12.00% 9.00%
Depreciation 17 27 28 27 30 30 21 19 25 23
Interest 0 1 1 0 1 0 0 0 0 0
Profit Before Tax 312 273 314 253 233 355 158 99 115 83
Tax 77 72 85 61 57 101 56 38 36 30
Net Profit 234 201 230 193 177 254 102 61 79 54
Earnings Per Share (₹) 141.00 121.00 138.00 116.00 107.00 153.00 505.27 56.60 47.70 32.30

PGHL Balance Sheet — Assets, Liabilities & Shareholders' Equity

PGHL total assets ₹841 Cr, total equity ₹525 Cr, total liabilities ₹ Cr (2026) — ROE 44.6%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2018 2017 2016 2015
ASSETS
Total Assets 841 794 794 1,101 888 986 1,176 1,760 991 879 784
Current Assets 556 526 524 796 608 727 954 1,534 752 636 572
Fixed Assets 116 116 129 144 112 104 101 104 115 111 132
Capital Work in Progress 14 11 6 33 41 39 22 17 9 30 7
Investments 137 0 0 0 0 0 0 0 70 28 42
Other Assets 0 667 660 925 736 843 1,053 1,639 797 711 603
LIABILITIES
Total Liabilities
Current Liabilities 62 42 37 46 40 44 42 27 33 29 27
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 525 537 538 751 617 704 906 1,540 733 664 592
Share Capital 17 17 17 17 17 17 17 17 17 17 17
Reserves & Surplus 508 520 522 734 600 687 890 1,524 717 647 575

PGHL Cash Flow Statement — Operating, Investing & Financing

Procter & Gamble Health operating cash flow ₹169 Cr, investing ₹10 Cr, financing ₹-235 Cr, net cash flow ₹-57 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2018 March 2017 March 2016 March 2015
Operating Activities 169 228 236 170 247 235 -130 54 107 84
Investing Activities 10 -7 -22 -26 -32 165 1,270 -48 -75 -68
Financing Activities -235 -418 -99 -289 -387 -883 -30 -22 -15 -12
Net Cash Flow -57 -197 116 -145 -172 -483 1,109 -16 17 4